JP2005523309A5 - - Google Patents

Download PDF

Info

Publication number
JP2005523309A5
JP2005523309A5 JP2003583368A JP2003583368A JP2005523309A5 JP 2005523309 A5 JP2005523309 A5 JP 2005523309A5 JP 2003583368 A JP2003583368 A JP 2003583368A JP 2003583368 A JP2003583368 A JP 2003583368A JP 2005523309 A5 JP2005523309 A5 JP 2005523309A5
Authority
JP
Japan
Prior art keywords
dosage form
antibiotic
product
max
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003583368A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005523309A (ja
Filing date
Publication date
Priority claimed from US10/027,866 external-priority patent/US6663890B2/en
Priority claimed from US10/027,366 external-priority patent/US6667057B2/en
Priority claimed from US10/027,609 external-priority patent/US6669948B2/en
Priority claimed from US10/028,595 external-priority patent/US6663891B2/en
Priority claimed from US10/028,590 external-priority patent/US6730320B2/en
Priority claimed from US10/027,837 external-priority patent/US6667042B2/en
Application filed filed Critical
Priority claimed from PCT/US2002/040809 external-priority patent/WO2003086344A1/fr
Publication of JP2005523309A publication Critical patent/JP2005523309A/ja
Publication of JP2005523309A5 publication Critical patent/JP2005523309A5/ja
Withdrawn legal-status Critical Current

Links

JP2003583368A 2001-12-20 2002-12-20 抗生物質産物、その使用法と製剤 Withdrawn JP2005523309A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US10/027,866 US6663890B2 (en) 2000-02-24 2001-12-20 Metronidazole antibiotic product, use and formulation thereof
US10/027,366 US6667057B2 (en) 2000-02-24 2001-12-20 Levofloxacin antibiotic product, use and formulation thereof
US10/027,609 US6669948B2 (en) 2000-02-24 2001-12-20 Antibiotic product, use and formulation thereof
US10/028,595 US6663891B2 (en) 2000-02-24 2001-12-20 Erythromyacin antibiotic product, use and formulation thereof
US10/028,590 US6730320B2 (en) 2000-02-24 2001-12-20 Tetracycline antibiotic product, use and formulation thereof
US10/027,837 US6667042B2 (en) 2000-02-24 2001-12-20 Fluroquinilone antibiotic product, use and formulation thereof
PCT/US2002/040809 WO2003086344A1 (fr) 2001-12-20 2002-12-20 Produit antibiotique, son utilisation et sa formulation

Publications (2)

Publication Number Publication Date
JP2005523309A JP2005523309A (ja) 2005-08-04
JP2005523309A5 true JP2005523309A5 (fr) 2006-02-16

Family

ID=29255716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003583368A Withdrawn JP2005523309A (ja) 2001-12-20 2002-12-20 抗生物質産物、その使用法と製剤

Country Status (5)

Country Link
EP (1) EP1465591A1 (fr)
JP (1) JP2005523309A (fr)
AU (1) AU2002359768A1 (fr)
CA (1) CA2470016A1 (fr)
WO (1) WO2003086344A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
WO2005009365A2 (fr) * 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Produit antibiotique, son utilisation et sa formulation
PT1883396E (pt) 2005-05-18 2013-10-08 Centre Nat Rech Scient Administração colónica de adsorventes
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8048413B2 (en) 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
JP5318400B2 (ja) * 2006-11-20 2013-10-16 第一三共株式会社 レボフロキサシン含有錠剤
JP5788142B2 (ja) * 2006-12-04 2015-09-30 シオノギ インコーポレイテッド 変性放出アモキシシリン製剤
US20130259947A1 (en) * 2010-11-29 2013-10-03 Dr. Reddy's Laboratories Ltd. Oral metronidazole pharmaceutical compositions
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
GB201210184D0 (en) * 2012-06-11 2012-07-25 Univ Leuven Kath Formulations of metronidazole for the treatment of pouchitis
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011692A (en) * 1985-12-28 1991-04-30 Sumitomo Pharmaceuticals Company, Limited Sustained pulsewise release pharmaceutical preparation
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
IL119627A (en) * 1996-11-17 2002-03-10 Yissum Res Dev Co PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT

Similar Documents

Publication Publication Date Title
JP2005523309A5 (fr)
Berlucchi et al. Update on treatment of Marshall's syndrome (PFAPA syndrome): report of five cases with review of the literature
JP2006528699A5 (fr)
DE69735093D1 (de) ARZNEIMITTEL ZUR GESTEUERTEN FREISETZUNG VON beta LACTAM ANTIBIOTIKA
JP2004502752A5 (fr)
ES2122810T3 (es) Formulacion de liberacion controlada para medicamentos basicos poco solubles.
EP1270005A3 (fr) Formulation comprenant de l'amoxicilline et un acide organique
BR0112532A (pt) Composição farmacêutica oral, sistema galênico e uso da composição
EP2260870A2 (fr) Traitement de maladies infectieuse par des mélanges de dérivés de thioxanthène avec des agents anti-infectieux
JPH0692850A (ja) 胃腸障害治療薬
MX2011002185A (es) Composiciones y metodos de tratamiento que comprenden ceftarolina.
WO2005030109A3 (fr) Schema posologique pour l'administration d'antibiotiques de la classe des rifamycines
Jewesson Pharmaceutical, pharmacokinetic and other considerations for intravenous to oral stepdown therapy
Centers for Disease Control and Prevention (CDC Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis
DiPersio et al. Fluoroquinolone-resistant Moraxella catarrhalis in a patient with pneumonia: report from the SENTRY Antimicrobial Surveillance Program (1998)
JP2011502103A (ja) カルバペネム類を含む殺菌性抗mrsa活性医薬組成物
PICHICHERO Therapeutic considerations for management of otitis media, sinusitis, and tonsillopharyngitis
WO2017209588A3 (fr) Formulation pharmaceutique de cinéol et d'amoxicilline
JP2006528189A5 (fr)
JP2006528190A5 (fr)
DK1461017T3 (da) Farmaceutisk sammensætning til styret frigivelse af et beta-lactam-antibiotikum
JP2006528185A5 (fr)
JP2007502294A5 (fr)
CN101505740A (zh) 改进的细菌感染治疗方法
EP0911030A3 (fr) Compositions antimicrobiennes contenant des dérivés de vinylpyrrolidinone-céphalosporine et un antibiotique carbapénème ou un inhibiteur du béta-lactamase